Board Meeting Intimation for Prior Intimation Of The Board Meeting Pursuant To Regulation 29(1) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015
20-May-2026 | Source : BSEMahamaya Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 inter alia to consider and approve We wish to inform you that a meeting of the Board of Directors of Mahamaya Lifesciences Limited is scheduled to be held on Monday May 25 2026 interalia to consider and approve the following agenda: 1. The Audited Standalone Financial Results of the Company for the half year and financial year ended 31.03.2026 along with the Audit Report thereon. 2. The Audited Consolidated Financial Results of the Company for the half year and financial year ended 31.03.2026 along with the Audit Report thereon.
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
15-May-2026 | Source : BSESubmission of Monitoring Agency Report for the half year ended on March 31 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
05-May-2026 | Source : BSENon Applicability of Annual Secretarial Compliance Report for the financial year ended on 31.03.2026 under Regulation 24A of SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015.
Corporate Actions
25 May 2026
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






